Abstract:BACKGROUND:Whereas several interventions can effectively lower lipid levels in people at risk for atherosclerotic cardiovascular disease (ASCVD), cardiovascular event risks remain, suggesting an unmet medical need to identify factors contributing to cardiovascular event risk. Monocytes and macrophages play central roles in atherosclerosis, but studies have yet to provide a detailed view of macrophage populations involved in increased ASCVD risk. METHODS:A novel macrophage foaming analytics tool, AtheroSpectrum, was developed using 2 quantitative indices depicting lipid metabolism and the inflammatory status of macrophages. A machine learning algorithm was developed to analyze gene expression patterns in the peripheral monocyte transcriptome of MESA participants (Multi-Ethnic Study of Atherosclerosis; set 1; n=911). A list of 30 genes was generated and integrated with traditional risk factors to create an ASCVD risk prediction model (30-gene cardiovascular disease risk score [CR-30]), which was subsequently validated in the remaining MESA participants (set 2; n=228); performance of CR-30 was also tested in 2 independent human atherosclerotic tissue transcriptome data sets (GTEx [Genotype-Tissue Expression] and GSE43292). RESULTS:Using single-cell transcriptomic profiles (GSE97310, GSE116240, GSE97941, and FR-FCM-Z23S), AtheroSpectrum detected 2 distinct programs in plaque macrophages-homeostatic foaming and inflammatory pathogenic foaming-the latter of which was positively associated with severity of atherosclerosis in multiple studies. A pool of 2209 pathogenic foaming genes was extracted and screened to select a subset of 30 genes correlated with cardiovascular event in MESA set 1. A cardiovascular disease risk score model (CR-30) was then developed by incorporating this gene set with traditional variables sensitive to cardiovascular event in MESA set 1 after cross-validation generalizability analysis. The performance of CR-30 was then tested in MESA set 2 (P=2.60×10-4; area under the receiver operating characteristic curve, 0.742) and 2 independent data sets (GTEx: P=7.32×10-17; area under the receiver operating characteristic curve, 0.664; GSE43292: P=7.04×10-2; area under the receiver operating characteristic curve, 0.633). Model sensitivity tests confirmed the contribution of the 30-gene panel to the prediction model (likelihood ratio test; df=31, P=0.03). CONCLUSIONS:Our novel computational program (AtheroSpectrum) identified a specific gene expression profile associated with inflammatory macrophage foam cells. A subset of 30 genes expressed in circulating monocytes jointly contributed to prediction of symptomatic atherosclerotic vascular disease. Incorporating a pathogenic foaming gene set with known risk factors can significantly strengthen the power to predict ASCVD risk. Our programs may facilitate both mechanistic investigations and development of therapeutic and prognostic strategies for ASCVD risk.

Single cell transcriptomics based-MacSpectrum reveals novel macrophage activation signatures in diseases.

BAF60a Deficiency in Macrophage Promotes Diet-Induced Obesity and Metabolic Inflammation

Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation

Macrophage heterogeneity in cardiometabolic disease

Adipose tissue macrophage heterogeneity in the single-cell genomics era

Cellular Phenotypic Analysis of Macrophage Activation Unveils Kinetic Responses of Agents Targeting Phosphorylation

Integrated metabolic-transcriptomic network identifies immunometabolic modulations in human macrophages

Metabolomic analysis reveals macrophage metabolic reprogramming and polarization under different nutritional cues

Adipose tissue macrophages: Regulators of adipose tissue immunometabolism during obesity

A lipid-associated macrophage lineage rewires the spatial landscape of adipose tissue in early obesity

MicroRNA Regulated Macrophage Activation in Obesity.

AtheroSpectrum Reveals Novel Macrophage Foam Cell Gene Signatures Associated With Atherosclerotic Cardiovascular Disease Risk.

Exploring the full spectrum of macrophage activation

Macspectrum Yields Unprecedented Resolution of Full Spectrum Macrophage Activation States in Atherosclerosis

Metabolic Regulation of Adipose Tissue Macrophage Function in Obesity and Diabetes

An in vitro model of adipose tissue-associated macrophages

Heterogeneity of adipose tissue-resident macrophages-beyond M1/M2 paradigm

Dynamic Roles and Expanding Diversity of Adipose Tissue Macrophages in Obesity

The Macrophage Switch in Obesity Development

Adipose tissue macrophages as potential targets for obesity and metabolic diseases

Unraveling the complex roles of macrophages in obese adipose tissue: an overview